APPLICATION
NDA219962
TYPE
NDA
ORIGINAL APPROVAL
2026-07-24
LATEST ACTION
2026-07-24
DOSAGE FORM
TABLET
MARKETING STATUS
Over-the-counter
Products
TYLENOL WITH NAPROXENOver-the-counter
NAPROXEN SODIUM, ACETAMINOPHEN 110MG/325MG · TABLET
Approval history
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.